BCL2A1 and glioblastoma: TCGA, CGGA, Rembrandt and Gravendeel were utilized to explore differences in BCL2A1 expression among GBM subtypes, and the results confirmed that BCL2A1 expression was enriched in the mesenchymal subtype (Figure 3A).